http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201307556-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17bdf0559a425282e77af6af2aaf6228 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952dec25c6233a1095dbb4d723646108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d889b22a1f25b69b6ad0811a20f630bf |
| publicationDate | 2013-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201307556-A |
| titleOfInvention | Establishment of a patient- or individual-specific cardiomyocyte cell line from human induced pluripotent stem cells (iPSCs) |
| abstract | Described herein are compositions and methods for producing a patient-specific, proliferative, and substantially pure cardiomyocyte strain from a multi-functional stem cell (iPSC). The patient-specific cardiomyocyte cell line of the present invention is suitable for research, drug screening, and autologous cell-based therapy. The method of the invention is simple and reproducible and produces cardiomyocytes with high purity and proliferative capacity. |
| priorityDate | 2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.